Commercial agreement includes molecular diagnostics for the growing aquaculture and aquamarine market Paris, France and Camberley, UK – 17 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its molecular testing division, Primerdesign Ltd (“Primerdesign”), has signed an exclusive commercial agreement with Atothis SARL, part of VGS Invest
Visit PageYear: 2020
Information mensuelle le contrat de liquidité et sur le nombre total de droits de vote
Paris, France et Camberley, Royaume-Uni – 2 janvier 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat de liquidité confié à Invest Securities SA (le « Contrat de liquidité »). Le contrat de liquidité est régi par le droit français
Visit PageLiquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 2 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit Page